CVE-2024-4424

Stored XSS in CemiPark

Description

The access control in CemiPark software does not properly validate user-entered data, which allows the stored cross-site scripting (XSS) attack. The parameters used to enter data into the system do not have appropriate validation, which makes possible to smuggle in HTML/JavaScript code. This code will be executed in the user's browser space.This issue affects CemiPark software: 4.5, 4.7, 5.03 and potentially others. The vendor refused to provide the specific range of affected products.

Category

6.1
CVSS
Severity: Medium
CVSS 3.1 •
EPSS 0.10%
Third-Party Advisory cert.pl Third-Party Advisory cert.pl
Affected: CEMI Tomasz Pawełek CemiPark
Published at:
Updated at:

References

Link Tags
https://cert.pl/en/posts/2024/05/CVE-2024-4423/ third party advisory
https://cert.pl/posts/2024/05/CVE-2024-4423/ third party advisory
http://cemi.pl/ product

Frequently Asked Questions

What is the severity of CVE-2024-4424?
CVE-2024-4424 has been scored as a medium severity vulnerability.
How to fix CVE-2024-4424?
To fix CVE-2024-4424, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2024-4424 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2024-4424 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2024-4424?
CVE-2024-4424 affects CEMI Tomasz Pawełek CemiPark.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.